Genmab (NASDAQ:GMAB) has released new findings regarding its cancer therapy Rina-S, currently under investigation for ...

A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug ...

A doctor has revealed that certain contraceptive pills could actually reduce your risk of a serious cancer that affects women ...

Investing.com -- Genmab (NASDAQ: GMAB) has unveiled new data for its cancer drug Rina-S, which is being tested for use in endometrial cancer. This follows promising early results from trials in ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endome | Genmab has shared the first data on ...

A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug dostarlimab with ...

Routine ultrasonography may trigger needless biopsies and hysteroscopies, say experts on quaternary prevention in cancer care ...

Patients with BRCA-altered uterine leiomyosarcoma treated with PARP inhibitors demonstrated encouraging outcomes.

Women with vs. without PCOS had a significantly increased risk for endometrial cancer, confirming findings from previous ...

Suneel Kamath, MD, presented an analysis of federal cancer research funding disparities and their ripple effects on care delivery and outcomes.

Lurie Cancer Center is hosting a survivors' walk and 5K celebration this Sunday at Grant Park. More than 3,000 cancer ...

Scientists have found that global warming in the Middle East and North Africa is making breast, ovarian, uterine, and ...